News
Zacks Investment Research on MSN1d
Novo Nordisk (NVO) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest trading session, Novo Nordisk (NVO) closed at $47.00, marking a -6.06% move from the previous day. This change lagged the S&P 500's 0.37% loss on the day. Elsewhere, the Dow saw a ...
Novo Nordisk stock plunges 22% after slashing 2025 sales and profit outlooks, citing weak GLP-1 drugs' uptake and rising ...
Tempus AI and NVIDIA are both actively working at the intersection of AI and healthcare. Tempus AI, while advancing precision ...
Novo Nordisk's Sell-Off Has Gone Too Far Jul. 06, 2025 9:33 AM ET Novo Nordisk A/S (NVO) Stock, NONOF Stock, NVON:CA Stock NVO, NONOF, NVON:CA 34 Comments Oakoff Investments Investing ...
SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.
Eli Lilly (LLY 0.90%) and Novo Nordisk (NVO 1.34%) are two phenomenal growth stocks that investors probably can't go wrong with when investing in for the long term. They are leaders in the GLP-1 ...
Today's Research Daily features new research reports on 16 major stocks, including SAP SE, Novo Nordisk A/S and Thermo Fisher Scientific Inc., as well a micro-cap stock FONAR Corp.
Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback